Maze Therapeutics' CEO Sold Over 30,000 Company Shares. What Does That Mean for Investors?

CEO Jason Coloma sold 32,564 shares in May for about $847,000 at a weighted average price of roughly $26.01 per share. The article is a factual insider transaction disclosure with no accompanying operational update, so the broader market impact is likely limited.

Analysis

CEO Jason Coloma sold 32,564 shares in May for about $847,000 at a weighted average price of roughly $26.01 per share. The article is a factual insider transaction disclosure with no accompanying operational update, so the broader market impact is likely limited.